“Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland”

[1]  Sterling C. Johnson,et al.  Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African Americans. , 2020, Journal of Alzheimer's disease : JAD.

[2]  Eric E. Smith,et al.  Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging–Detected Vascular Brain Injury , 2020, Stroke.

[3]  M. Albert,et al.  Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia. , 2019, JAMA.

[4]  D. Wechsler.  Wechsler Adult Intelligence Scale--Third Edition , 2019 .

[5]  P. Visser,et al.  Age dependency of risk factors for cognitive decline , 2018, BMC Geriatrics.

[6]  M. Folstein,et al.  Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention. , 2018, Journal of Alzheimer's disease : JAD.

[7]  R. Wong,et al.  Cognition and Context: Rural–Urban Differences in Cognitive Aging Among Older Mexican Adults , 2018, Journal of aging and health.

[8]  Zheng-yu Jin,et al.  Prevalence and Risk Factors of Cerebral Small Vessel Disease in a Chinese Population-Based Sample , 2018, Journal of stroke.

[9]  Lenore J. Launer,et al.  Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis , 2018, Neuroscience & Biobehavioral Reviews.

[10]  Eric J. Brunner,et al.  Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study , 2018, Alzheimer's & Dementia.

[11]  A. Heinz,et al.  Drink and Think: Impact of Alcohol on Cognitive Functions and Dementia – Evidence of Dose-Related Effects , 2017, Pharmacopsychiatry.

[12]  J. Millán-Calenti,et al.  Effects of Degree of Urbanization and Lifetime Longest-Held Occupation on Cognitive Impairment Prevalence in an Older Spanish Population , 2017, Front. Psychol..

[13]  A. Szuba,et al.  Prospective urban and rural epidemiology Poland – study design , 2016 .

[14]  Sudha Seshadri,et al.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.

[15]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention , 2016, Atherosclerosis.

[16]  N. Venketasubramanian,et al.  Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort. , 2016, Journal of Alzheimer's disease : JAD.

[17]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[18]  Richard Frayne,et al.  Early Cerebral Small Vessel Disease and Brain Volume, Cognition, and Gait , 2015, Annals of neurology.

[19]  Joanna M. Wardlaw,et al.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.

[20]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[21]  David S Knopman,et al.  Classification and epidemiology of MCI. , 2013, Clinics in geriatric medicine.

[22]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[23]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[24]  Klaus P. Ebmeier,et al.  Timing of onset of cognitive decline: results from Whitehall II prospective cohort study , 2012, BMJ : British Medical Journal.

[25]  I. Marzona.  The Standard Assessment of Global Activities in the Elderly (SAGE) scale: Validation process of a new tool for the assessment of disability in older adults , 2011 .

[26]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[27]  N. Venketasubramanian,et al.  The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke , 2010, Journal of the Neurological Sciences.

[28]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[29]  Giuseppe Mancia,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.

[30]  R. D'Agostino,et al.  Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.

[31]  Eric E. Smith,et al.  Metabolic syndrome , 2007, Neurology.

[32]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[33]  L. Radloff.  Center for Epidemiologic Studies Depression Scale (CES-D) , 2006 .

[34]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[35]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[36]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[37]  H. Soininen,et al.  Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[38]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[39]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[40]  A. Folsom,et al.  Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.

[41]  R. Petersen,et al.  Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.

[42]  T. Redman.  The Impact of , 1998 .

[43]  N. G. Gordon.  The Trail Making Test in neuropsychological diagnosis. , 1972, Journal of clinical psychology.